Literature DB >> 27052229

[Diagnosis, treatment and monitoring of diabetic eye control].

Stephan Radda1,2, Matthias Bolz3,4, Stefan Egger5,4, Vanessa Gasser-Steiner6,4, Martina Kralinger7,4, Stefan Mennel8,4, Christoph Scholda9,4, Ulrike Stolba10,4, Andreas Wedrich6,4, Katharina Krepler9,4.   

Abstract

Diabetes mellitus can cause diabetic retinopathy, diabetic macular edema, optic neuropathy, cataract or dysfunction of the eye muscles. The incidence of these defects correlates with disease duration and quality of metabolic control. Recommendations of the Austrian Diabetes Association for diagnosis, therapeutic procedures and requirements for adequate follow up depending on stage of diabetic eye disease are summarized.

Entities:  

Keywords:  Diabetic macular edema; Diabetic retinopathy; Intravitreal therapy; Retinal laser photocogulation; Vitrectomy

Mesh：

Substances：

Year:  2016        PMID： 27052229     DOI： 10.1007/s00508-016-0983-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  59 in total

1.  Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications.

Authors:  Per Flesner; Birgit Sander; Vibeke Henning; Hans-Henrik Parving; Morten Dornonville de la Cour; Henrik Lund-Andersen
Journal:  Acta Ophthalmol Scand       Date:  2002-02

2.  Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

Review 3.  Prevention of blindness in diabetic retinopathy.

Authors:  E M Kohner; P J Barry
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

4.  Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.

Authors:  Michael J Elman; Allison Ayala; Neil M Bressler; David Browning; Christina J Flaxel; Adam R Glassman; Lee M Jampol; Thomas W Stone
Journal:  Ophthalmology       Date:  2014-10-28       Impact factor: 12.079

5.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

6.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Neil M Bressler; Haijing Qin; Roy W Beck; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

7.  Effect of cataract surgery on the progression of diabetic retinopathy.

Authors:  Jin Chung; Mu-Yan Kim; Hyeun-Seung Kim; Jin-Seong Yoo; Young-Chun Lee
Journal:  J Cataract Refract Surg       Date:  2002-04       Impact factor: 3.351

8.  A diabetic retinopathy screening program as a strategy for blindness prevention.

Authors:  C González Villalpando; M E González Villalpando; S Martínez Díaz; D Rivera Martínez; B Arredondo Pérez; S Islas Andrade; M P Stern
Journal:  Arch Med Res       Date:  1997       Impact factor: 2.235

Review 9.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

10.  Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group.

Authors:  J Kinyoun; F Barton; M Fisher; L Hubbard; L Aiello; F Ferris
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.